In mice subjected to permanent coronary artery occlusion, MCC950 improved cardiac remodeling by lowering myocardial fibrosis, caspase-1 activation, inflammatory cell infiltration, and IL-18 and IL-1β expression levels (173). The gene discussed is IL1B; the disease is Myocardial fibrosis.